Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
IMNN
IMNN
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
IMNN News
IMUNON (IMNN) Q1 2026 Earnings Call Insights
May 12 2026
seekingalpha
Imunon Q1 Earnings Beat Expectations
May 12 2026
seekingalpha
IMUNON to Host Q1 2026 Financial Results Conference Call
May 05 2026
Newsfilter
Imunon Reports Improved Survival Rates and Extended Operating Runway
Mar 31 2026
Yahoo Finance
Imunon Q4 2025 Earnings Call Highlights
Mar 31 2026
seekingalpha
Imunon Reports FY Losses, EPS at -$6.83
Mar 31 2026
seekingalpha
Imunon Scheduled to Announce Q4 Earnings on March 30
Mar 30 2026
seekingalpha
Biotech Landscape Update: Regulatory Approvals and Mergers
Mar 27 2026
NASDAQ.COM
IMUNON Secures $7 Million from Institutional Investor in Direct Stock Offering
Dec 30 2025
Newsfilter
IMUNON Advances OVATION3 Study, Aiming for Breakthrough Therapy
Dec 29 2025
Globenewswire
IMUNON Advances OVATION3 Study, Aiming for Breakthrough Therapy
Dec 29 2025
Newsfilter
Imunon (IMNN) Q3 2025 Earnings Conference Call Transcript
Nov 13 2025
NASDAQ.COM
IMUNON Releases Financial Results for Q3 2025 and Offers Business Update
Nov 13 2025
Newsfilter
IMUNON's Public Webcast Showcases Resilience and Innovation in the Quest for the First Approved Ovarian Cancer Immunotherapy
Nov 10 2025
Newsfilter
IMUNON R&D Day: Chance to Listen to Clinical Trial Researchers Discuss the Promising Impact of IMNN-001 on Ovarian Cancer Therapy
Nov 07 2025
Newsfilter
VTYX, MEDP, INBX Surge in After-Hours Trading Following Important Announcements
Oct 23 2025
NASDAQ.COM
Show More News
